Thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
and	and	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
antineoplastic	antineoplastic	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
.	.	O	O	O	O

Five	five	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
carcinoma	carcinoma	O	DISEASE	OTHERS	I
developed	developed	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
(	(	O	O	O	O
characterized	characterized	O	O	O	O
by	by	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
insufficiency	insufficiency	O	DISEASE	OTHERS	I
,	,	O	O	O	O
microangiopathic	microangiopathic	O	O	OTHERS	I
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
usually	usually	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
)	)	O	O	O	O
after	after	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
bleomycin	bleomycin	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
vinca	vinca	O	O	OTHERS	I
alkaloid	alkaloid	O	O	OTHERS	I
.	.	O	O	O	O

One	one	O	O	O	O
patient	patient	O	O	O	O
had	had	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
thrombocytopenic	thrombocytopenic	O	O	OTHERS	I
purpura	purpura	O	O	OTHERS	I
,	,	O	O	O	O
three	three	O	O	O	O
the	the	O	O	O	O
hemolytic-uremic	hemolytic-uremic	O	O	O	O
syndrome	syndrome	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
one	one	O	O	O	O
an	an	O	O	O	O
apparent	apparent	O	O	O	O
forme	forme	O	O	O	O
fruste	fruste	O	O	O	O
of	of	O	O	O	O
one	one	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
disorders	disorders	O	O	O	O
.	.	O	O	O	O

Histologic	histologic	O	O	O	O
examination	examination	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
renal	renal	O	O	O	O
tissue	tissue	O	O	O	O
showed	showed	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
intravascular	intravascular	O	O	OTHERS	I
coagulation	coagulation	O	O	OTHERS	I
,	,	O	O	O	O
primarily	primarily	O	O	O	O
affecting	affecting	O	O	O	O
the	the	O	O	O	O
small	small	O	O	O	O
arteries	arteries	O	O	O	O
,	,	O	O	O	O
arterioles	arterioles	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
glomeruli	glomeruli	O	O	O	O
.	.	O	O	O	O

Because	because	O	O	O	O
each	each	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
tumor-free	tumor-free	O	O	O	O
or	or	O	O	O	O
had	had	O	O	O	O
only	only	O	O	O	O
a	a	O	O	O	O
small	small	O	O	O	O
tumor	tumor	O	DISEASE	OTHERS	I
at	at	O	O	O	O
the	the	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
syndrome	syndrome	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
may	may	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
.	.	O	O	O	O

Diagnosis	diagnosis	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
potentially	potentially	O	O	O	O
fatal	fatal	O	O	O	O
complication	complication	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
delayed	delayed	O	O	O	O
or	or	O	O	O	O
missed	missed	O	O	O	O
if	if	O	O	O	O
renal	renal	O	O	O	O
tissue	tissue	O	O	O	O
or	or	O	O	O	O
the	the	O	O	O	O
peripheral	peripheral	O	O	O	O
blood	blood	O	O	O	O
smear	smear	O	O	O	O
is	is	O	O	O	O
not	not	O	O	O	O
examined	examined	O	O	O	O
,	,	O	O	O	O
because	because	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
ascribed	ascribed	O	O	O	O
to	to	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
anemia	anemia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
to	to	O	O	O	O
drug-induced	drug-induced	O	O	O	O
bone	bone	O	DISEASE	OTHERS	I
marrow	marrow	O	DISEASE	OTHERS	I
suppression	suppression	O	DISEASE	OTHERS	I
.	.	O	O	O	O

